BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33487427)

  • 61. Transition of Treatment for Ground Glass Opacity-Dominant Non-Small Cell Lung Cancer.
    Handa Y; Tsutani Y; Okada M
    Front Oncol; 2021; 11():655651. PubMed ID: 33937064
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience.
    Yoshida J; Nagai K; Yokose T; Nishimura M; Kakinuma R; Ohmatsu H; Nishiwaki Y
    J Thorac Cardiovasc Surg; 2005 May; 129(5):991-6. PubMed ID: 15867771
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Maximum standardized uptake value of the primary tumor does not improve candidate selection for sublobar resection.
    Muraoka Y; Yoshida Y; Nakagawa K; Ito K; Watanabe H; Narita T; Watanabe SI; ; Yotsukura M; Motoi N; Yatabe Y
    J Thorac Cardiovasc Surg; 2022 May; 163(5):1656-1665.e3. PubMed ID: 34275620
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Sublobar curative resection for non-small-cell lung cancer].
    Bonnette P
    Bull Cancer; 2012 Nov; 99(11):1069-75. PubMed ID: 23092959
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Segmentectomy for ground glass-dominant invasive lung cancer with tumour diameter of 2-3 cm: protocol for a single-arm, multicentre, phase III trial (ECTOP1012).
    Chen S; Huang Q; Fu F; Wang Z; Zhang Y; Chen H
    BMJ Open; 2024 Jul; 14(7):e087088. PubMed ID: 38960464
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers.
    Chen K; Chen W; Cai J; Yang F; Lou F; Wang X; Zhang J; Zhao M; Zhang J; Wang J
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):371-379.e1. PubMed ID: 29092754
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical Features of Ground Glass Opacity-Dominant Lung Cancer Exceeding 3.0 cm in the Whole Tumor Size.
    Suzuki S; Sakurai H; Yotsukura M; Masai K; Asakura K; Nakagawa K; Motoi N; Watanabe SI
    Ann Thorac Surg; 2018 May; 105(5):1499-1506. PubMed ID: 29427615
    [TBL] [Abstract][Full Text] [Related]  

  • 68. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan.
    Suzuki K; Asamura H; Kusumoto M; Kondo H; Tsuchiya R
    Ann Thorac Surg; 2002 Nov; 74(5):1635-9. PubMed ID: 12440622
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer.
    Okami J; Ito Y; Higashiyama M; Nakayama T; Tokunaga T; Maeda J; Kodama K
    Ann Thorac Surg; 2010 Nov; 90(5):1651-6. PubMed ID: 20971281
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer.
    Miyoshi T; Ito H; Wakabayashi M; Hashimoto T; Sekino Y; Suzuki K; Tsuboi M; Moriya Y; Yoshino I; Isaka T; Hattori A; Mimae T; Isaka M; Maniwa T; Endo M; Yoshioka H; Nakagawa K; Nakajima R; Tsutani Y; Saji H; Okada M; Aokage K; Fukuda H; Watanabe SI
    Eur J Cardiothorac Surg; 2023 Dec; 64(6):. PubMed ID: 37930048
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic Classification of Multiple Primary Lung Cancers Based on a Ground-Glass Opacity Component.
    Hattori A; Takamochi K; Oh S; Suzuki K
    Ann Thorac Surg; 2020 Feb; 109(2):420-427. PubMed ID: 31593656
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter.
    Yamada S; Kohno T
    Ann Thorac Surg; 2004 Jun; 77(6):1911-5. PubMed ID: 15172235
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis.
    Paul S; Lee PC; Mao J; Isaacs AJ; Sedrakyan A
    BMJ; 2016 Jul; 354():i3570. PubMed ID: 27400862
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience.
    Kim D; Ferraris VA; Davenport D; Saha S
    South Med J; 2015 Apr; 108(4):230-4. PubMed ID: 25871994
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of the ground-glass opacity ratio in resected lung adenocarcinoma.
    Huang TW; Lin KH; Huang HK; Chen YI; Ko KH; Chang CK; Hsu HH; Chang H; Lee SC
    Eur J Cardiothorac Surg; 2018 Aug; 54(2):229-234. PubMed ID: 29471517
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201).
    Suzuki K; Koike T; Asakawa T; Kusumoto M; Asamura H; Nagai K; Tada H; Mitsudomi T; Tsuboi M; Shibata T; Fukuda H; Kato H;
    J Thorac Oncol; 2011 Apr; 6(4):751-6. PubMed ID: 21325976
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Application of indocyanine green fluorescence for precision sublobar resection.
    Zhang C; Lin H; Fu R; Zhang T; Nie Q; Dong S; Yang XN; Wu YL; Zhong WZ
    Thorac Cancer; 2019 Apr; 10(4):624-630. PubMed ID: 30734507
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Precise Anatomical Sublobar Resection Using a 3D Medical Image Analyzer and Fluorescence-Guided Surgery With Transbronchial Instillation of Indocyanine Green.
    Sekine Y; Itoh T; Toyoda T; Kaiho T; Koh E; Kamata T; Hoshino H; Hata A
    Semin Thorac Cardiovasc Surg; 2019; 31(3):595-602. PubMed ID: 30616007
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer.
    Maeyashiki T; Suzuki K; Hattori A; Matsunaga T; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2013 May; 43(5):915-8. PubMed ID: 23024235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.